Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 7201–7220 of 17,529 recalls

June 12, 2019· Infusion Options, Inc.

Recalled Item: TRASTUZUMAB 427 MG / 250 ml NS IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: InFLIXimab 300 mg / 250 ml 0.9% NACL IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: OPDIVO 200 mg /100 ML NS VPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: PACLITAXEL 258 MG / 500 ML NS IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: AVASTIN 630 MG / 100 ML 0.9% NACL IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: PERJETA 420 MG/250 ml 0.9% NACL IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: IRINOTECAN 250 MG /500 ml D5W IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: Cyclophosphamide 840 MG / 250 ML NS IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: ADO-TRASTUZUMAB 210 MG/250 ml NS

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: ATEZOLIZUMAB 1200 MG / 250 ML 0.9% NACL

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: PACLITAXEL PROTEIN 175 MG/100 ML NS IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: PRESERVATIVE FREE 0.9% NACL 5 ML SYR

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: CARFILZOMIB 65 MG IN 50 ML D5W IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: PEMETREXED 910 MG QS 100 ML NS IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: AZACITIDINE 125 MG / 5 ML SUB-Q SYRINGE

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: BEVACIZUMAB 784 MG / 100 ML NS IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: Etoposide 184 MG / 500 ml NS IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: ENTYVIO 300 MG /250 ML 0.9% NACL

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: ERIBULIN 1.12 MG / 100 ML NS IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 12, 2019· Infusion Options, Inc.

Recalled Item: CETUXIMAB 335 MG / 167.5 ML IVPB

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund